Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Myelomonocytic, Chronic × pertuzumab × Clear all

Sponsor

Conditions

Breast Neoplasms 41 Ovarian Neoplasms 4 Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Solid Tumor 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Inflammatory Breast Neoplasms 2 HER2-positive Breast Cancer 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Patient Preference 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Multiple Endocrine Neoplasia 1 Malignant Solid Neoplasm 1 Lung Neoplasms 1 Locally Advanced Breast Cancer 1 Her2-Positive Breast Cancer 1 HER2-positive Metastatic Breast Cancer 1 HER2-positive Early Breast Cancer 1 Fallopian Tube Neoplasms 1 Carcinoma, Neuroendocrine 1 Carcinoid Tumor 1 Breast Neoplasms, Male 1 Biliary Tract Neoplasms 1

Interventions

fludarabine phosphate 32 Cyclophosphamide 27 Whole-Body Irradiation 25 Mycophenolic Acid 24 Azacitidine 24 Tacrolimus 20 Peripheral Blood Stem Cell Transplantation 20 Busulfan 20 Cyclosporine 14 Methotrexate 12 Antilymphocyte Serum 12 Decitabine 11 Cytarabine 11 Melphalan 10 Filgrastim 8 fludarabine 7 Granulocyte Colony-Stimulating Factor 7 Etoposide 7 thymoglobulin 6 Sirolimus 6 Rituximab 6 Radiotherapy 6 Cord Blood Stem Cell Transplantation 6 Clofarabine 6 venetoclax 5 Cyclosporins 5 Sorafenib 4 Injections 4 Flow Cytometry 4 pevonedistat 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡